Symbols / MD Stock $22.75 +1.07% Pediatrix Medical Group, Inc.

Healthcare • Medical Care Facilities • United States • NYQ
MD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Mark S. Ordan
Exch · Country NYQ · United States
Market Cap 1.89B
Enterprise Value 1.98B
Income 165.39M
Sales 1.91B
FCF (ttm) 190.33M
Book/sh 10.68
Cash/sh 6.16
Employees 4,280
Insider 10d —
IPO Sep 20, 1995
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 11.73
Forward P/E 9.78
PEG 0.24
P/S 0.99
P/B 2.13
P/C —
EV/EBITDA 7.83
EV/Sales 1.03
Quick Ratio 1.62
Current Ratio 1.66
Debt/Eq 73.29
LT Debt/Eq —
EPS (ttm) 1.94
EPS next Y 2.33
EPS Growth 11.40%
Revenue Growth -1.70%
EPS Gr Q/Q 10.50%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-19
ROA 6.57%
ROE 20.28%
ROIC —
Gross Margin 25.80%
Oper. Margin 11.07%
Profit Margin 8.64%
Shs Outstand 83.07M
Shs Float 79.95M
Insider Own 2.31%
Instit Own 105.80%
Short Float 5.88%
Short Ratio 3.99
Short Interest 3.46M
52W High 24.99
vs 52W High -8.96%
52W Low 11.84
vs 52W Low 92.15%
Beta 0.71
Impl. Vol. 0.78%
Rel Volume 0.71
Avg Volume 855.62K
Volume 606.46K
Target (mean) $22.17
Tgt Median $21.50
Tgt Low $19.00
Tgt High $27.00
# Analysts 6
Recom Buy
Prev Close $22.51
Price $22.75
Change 1.07%
About

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$22.17
Mean price target
2. Current target
$22.75
Latest analyst target
3. DCF / Fair value
$41.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$22.75
Low
$19.00
High
$27.00
Mean
$22.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-13 main Truist Securities Hold → Hold $23
2026-02-24 main UBS Neutral → Neutral $22
2026-02-20 main Truist Securities Hold → Hold $21
2025-11-10 main Truist Securities Hold → Hold $24
2025-11-05 main UBS Neutral → Neutral $23
2025-09-05 main Leerink Partners Market Perform → Market Perform $17
2025-08-14 main UBS Neutral → Neutral $17
2025-05-12 main UBS Neutral → Neutral $16
2025-05-08 main Macquarie Outperform → Outperform $20
2025-04-11 main Truist Securities Hold → Hold $16
2025-02-21 main UBS Neutral → Neutral $19
2025-02-21 main Truist Securities Hold → Hold $18
2025-01-06 main Truist Securities Hold → Hold $15
2024-12-16 init Macquarie — → Outperform $18
2024-11-19 main Mizuho Neutral → Neutral $15
2024-11-05 main UBS Neutral → Neutral $17
2024-11-05 main Jefferies Buy → Buy $18
2024-11-04 main Deutsche Bank Hold → Hold $15
2024-11-04 main Truist Securities Hold → Hold $16
2024-11-04 main Mizuho Neutral → Neutral $15
News
RSS: Latest MD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-27 MOORE MARY ANN E General Counsel — 39,925 $0.00 $0
2025-12-15 ORDAN MARK S Chief Executive Officer — 23,000 $22.41 $515,430
2025-11-17 RUCKER MICHAEL A Director — 10,478 $23.00 $240,994
2025-11-06 LINYNSKY LAURA A Director — 10,000 $21.65 $216,500
2025-08-20 MCEACHIN THOMAS A Director — 54,646 $0.00 $0
2025-08-01 NEWMAN KURT DOUGLAS M.D. Director — 9,737 $0.00 $0
2025-08-01 NEEB DON GREGORY Officer — 81,346 $0.00 $0
2025-06-10 MOORE MARY ANN E General Counsel — 10,371 $0.00 $0
2025-05-30 MOORE MARY ANN E General Counsel — 53,004 $0.00 $0
2025-05-30 ROSSI KASANDRA H Chief Financial Officer — 26,502 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,913.85
-4.92%
2,012.92
+0.92%
1,994.64
+1.15%
1,972.02
Operating Revenue
1,901.64
-5.40%
2,010.29
+0.92%
1,992.05
+2.06%
1,951.75
Cost Of Revenue
1,420.15
-8.88%
1,558.58
-0.92%
1,573.08
+4.52%
1,504.99
Reconciled Cost Of Revenue
1,420.15
-8.88%
1,558.58
-0.92%
1,573.08
+4.52%
1,504.99
Gross Profit
493.70
+8.66%
454.34
+7.78%
421.56
-9.74%
467.03
Operating Expense
262.62
-2.97%
270.66
+2.64%
263.71
-1.24%
267.03
Selling General And Administration
240.79
+0.99%
238.44
+4.79%
227.54
-1.67%
231.40
General And Administrative Expense
240.79
+0.99%
238.44
+4.79%
227.54
-1.67%
231.40
Other Gand A
240.79
+0.99%
238.44
+4.79%
227.54
-1.67%
231.40
Total Expenses
1,682.76
-8.01%
1,829.24
-0.41%
1,836.79
+3.65%
1,772.02
Operating Income
231.09
+25.81%
183.68
+16.36%
157.85
-21.07%
200.00
Total Operating Income As Reported
208.81
+403.89%
-68.71
-1038.57%
7.32
-95.76%
172.69
EBITDA
274.22
+1066.53%
-28.37
-194.93%
29.89
-80.93%
156.70
Normalized EBITDA
256.55
+17.55%
218.25
+11.31%
196.08
-17.39%
237.36
Reconciled Depreciation
21.83
-32.27%
32.23
-10.91%
36.17
+1.50%
35.64
EBIT
252.40
+516.51%
-60.60
-864.32%
-6.28
-105.19%
121.06
Total Unusual Items
17.68
+107.17%
-246.62
-48.40%
-166.19
-106.05%
-80.66
Total Unusual Items Excluding Goodwill
17.68
+107.17%
-246.62
-48.40%
-166.19
-106.05%
-80.66
Special Income Charges
-1.37
+99.46%
-252.39
-48.00%
-170.53
-102.22%
-84.33
Other Special Charges
—
—
—
57.02
Impairment Of Capital Assets
0.00
-100.00%
178.44
+20.31%
148.31
0.00
Restructuring And Mergern Acquisition
22.27
-65.34%
64.26
+2795.90%
2.22
-91.88%
27.31
Write Off
0.00
0.00
-100.00%
20.00
0.00
Net Income
165.39
+266.94%
-99.07
-64.00%
-60.41
-191.07%
66.33
Pretax Income
216.43
+313.57%
-101.34
-109.56%
-48.36
-159.43%
81.37
Net Non Operating Interest Income Expense
-35.97
+11.73%
-40.74
+3.17%
-42.08
-6.00%
-39.70
Interest Expense Non Operating
35.97
-11.73%
40.74
-3.17%
42.08
+6.00%
39.70
Net Interest Income
-35.97
+11.73%
-40.74
+3.17%
-42.08
-6.00%
-39.70
Interest Expense
35.97
-11.73%
40.74
-3.17%
42.08
+6.00%
39.70
Other Income Expense
21.31
+108.72%
-244.28
-48.83%
-164.14
-107.94%
-78.94
Gain On Sale Of Security
19.05
+230.01%
5.77
+33.03%
4.34
+18.17%
3.67
Gain On Sale Of Business
20.91
+315.55%
-9.70
0.00
0.00
Tax Provision
51.04
+2346.65%
-2.27
-118.86%
12.05
-35.93%
18.81
Tax Rate For Calcs
0.00
+952.68%
0.00
-89.33%
0.00
-9.09%
0.00
Tax Effect Of Unusual Items
4.17
+175.46%
-5.52
+84.17%
-34.90
-87.32%
-18.63
Net Income Including Noncontrolling Interests
165.39
+266.94%
-99.07
-64.00%
-60.41
-191.07%
66.33
Net Income From Continuing Operation Net Minority Interest
165.39
+266.94%
-99.07
-64.00%
-60.41
-196.55%
62.57
Net Income From Continuing And Discontinued Operation
165.39
+266.94%
-99.07
-64.00%
-60.41
-191.07%
66.33
Net Income Continuous Operations
165.39
+266.94%
-99.07
-64.00%
-60.41
-196.55%
62.56
Net Income Discontinuous Operations
—
0.00
0.00
-100.00%
3.77
Minority Interests
—
0.00
0.00
-100.00%
0.00
Normalized Income
151.88
+6.93%
142.03
+100.37%
70.88
-43.11%
124.59
Net Income Common Stockholders
165.39
+266.94%
-99.07
-64.00%
-60.41
-191.07%
66.33
Diluted EPS
1.94
+263.03%
-1.19
-63.01%
-0.73
-192.41%
0.79
Basic EPS
1.97
+270.75%
-1.15
-60.47%
-0.72
-189.90%
0.80
Basic Average Shares
84.08
-2.08%
85.87
+2.20%
84.02
+1.29%
82.95
Diluted Average Shares
85.27
-0.70%
85.87
+2.20%
84.02
-0.12%
84.12
Diluted NI Availto Com Stockholders
165.39
+266.94%
-99.07
-64.00%
-60.41
-191.07%
66.33
Depreciation Amortization Depletion Income Statement
21.83
-32.27%
32.23
-10.91%
36.17
+1.50%
35.64
Depreciation And Amortization In Income Statement
21.83
-32.27%
32.23
-10.91%
36.17
+1.50%
35.64
Earnings From Equity Interest
3.63
+54.99%
2.34
+13.95%
2.06
+19.45%
1.72
Gain On Sale Of PPE
—
—
0.00
0.00
Line Item Trend 2023-12-31
Total Assets
2,219.81
Current Assets
483.45
Cash Cash Equivalents And Short Term Investments
177.74
Cash And Cash Equivalents
73.26
Other Short Term Investments
104.48
Receivables
279.88
Accounts Receivable
272.31
Gross Accounts Receivable
1,379.21
Allowance For Doubtful Accounts Receivable
-1,106.90
Taxes Receivable
7.57
Prepaid Assets
13.53
Other Current Assets
12.31
Total Non Current Assets
1,736.36
Net PPE
145.93
Gross PPE
288.65
Accumulated Depreciation
-142.72
Properties
0.00
Land And Improvements
2.03
Buildings And Improvements
8.29
Other Properties
278.33
Goodwill And Other Intangible Assets
1,405.41
Goodwill
1,384.17
Other Intangible Assets
21.24
Non Current Deferred Assets
102.85
Non Current Deferred Taxes Assets
102.85
Other Non Current Assets
82.17
Total Liabilities Net Minority Interest
1,370.75
Current Liabilities
388.95
Payables And Accrued Expenses
352.96
Payables
73.29
Accounts Payable
34.59
Current Accrued Expenses
279.67
Total Tax Payable
38.70
Income Tax Payable
2.16
Current Debt And Capital Lease Obligation
35.99
Current Debt
12.50
Other Current Borrowings
12.50
Current Capital Lease Obligation
23.49
Total Non Current Liabilities Net Minority Interest
981.80
Long Term Debt And Capital Lease Obligation
665.66
Long Term Debt
611.59
Long Term Capital Lease Obligation
54.07
Non Current Deferred Liabilities
34.31
Non Current Deferred Taxes Liabilities
34.31
Other Non Current Liabilities
281.84
Stockholders Equity
849.06
Common Stock Equity
849.06
Capital Stock
0.84
Common Stock
0.84
Preferred Stock
0.00
Share Issued
84.02
Ordinary Shares Number
84.02
Treasury Shares Number
0.00
Additional Paid In Capital
999.91
Retained Earnings
-149.47
Gains Losses Not Affecting Retained Earnings
-2.21
Minority Interest
—
Other Equity Adjustments
-2.21
Total Equity Gross Minority Interest
849.06
Total Capitalization
1,460.65
Working Capital
94.51
Invested Capital
1,473.15
Total Debt
701.65
Net Debt
550.84
Capital Lease Obligations
77.56
Net Tangible Assets
-556.35
Tangible Book Value
-556.35
Interest Payable
8.26
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
271.09
+31.23%
206.57
+50.43%
137.32
-17.74%
166.94
Cash Flow From Continuing Operating Activities
274.74
+26.46%
217.25
+48.72%
146.08
-19.87%
182.31
Cash From Discontinued Operating Activities
-3.65
+65.83%
-10.68
-21.94%
-8.76
+43.04%
-15.37
Net Income From Continuing Operations
165.39
+266.94%
-99.07
-64.00%
-60.41
-196.55%
62.57
Depreciation Amortization Depletion
21.83
-32.27%
32.23
-10.91%
36.17
+1.50%
35.64
Depreciation And Amortization
21.83
-32.27%
32.23
-10.91%
36.17
+1.50%
35.64
Other Non Cash Items
-3.63
-79.73%
-2.02
-4.67%
-1.93
-201.00%
1.91
Stock Based Compensation
18.05
+52.05%
11.87
-3.69%
12.32
-23.59%
16.13
Asset Impairment Charge
0.00
-100.00%
178.44
+6.01%
168.31
0.00
Deferred Tax
52.19
+2550.05%
-2.13
-165.76%
3.24
+114.22%
-22.77
Deferred Income Tax
52.19
+2550.05%
-2.13
-165.76%
3.24
+114.22%
-22.77
Operating Gains Losses
-20.91
-315.55%
9.70
—
57.02
Gain Loss On Sale Of PPE
—
—
0.00
0.00
Change In Working Capital
41.83
-52.60%
88.24
+858.85%
-11.63
-136.54%
31.83
Change In Receivables
30.56
+196.91%
10.29
-60.83%
26.28
+574.04%
-5.54
Changes In Account Receivables
30.56
+196.91%
10.29
-60.83%
26.28
+574.04%
-5.54
Change In Prepaid Assets
-2.92
-183.50%
3.50
+580.35%
0.51
-96.77%
15.93
Change In Payables And Accrued Expense
28.33
-44.60%
51.14
+528.99%
-11.92
-2938.33%
0.42
Change In Payable
—
—
—
—
Change In Account Payable
—
—
—
—
Change In Other Working Capital
-1.21
+75.90%
-5.04
+76.76%
-21.68
-218.94%
18.23
Change In Other Current Assets
21.80
-35.37%
33.73
+47.60%
22.85
+32.89%
17.20
Change In Other Current Liabilities
-34.73
-545.38%
-5.38
+80.55%
-27.67
-92.17%
-14.40
Investing Cash Flow
-18.30
+48.33%
-35.41
+26.51%
-48.18
+15.41%
-56.95
Cash Flow From Continuing Investing Activities
-18.30
+48.33%
-35.41
+26.51%
-48.18
+15.41%
-56.95
Cash From Discontinued Investing Activities
—
—
0.00
0.00
Net PPE Purchase And Sale
-18.46
+16.18%
-22.02
+33.92%
-33.33
-12.19%
-29.71
Purchase Of PPE
-18.46
+16.18%
-22.02
+33.92%
-33.33
-12.19%
-29.71
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
-18.46
+16.18%
-22.02
+33.92%
-33.33
-12.19%
-29.71
Net Investment Purchase And Sale
-3.18
+73.64%
-12.05
-34.09%
-8.99
-1866.74%
-0.46
Purchase Of Investment
-29.85
+53.75%
-64.55
-102.38%
-31.89
-83.86%
-17.35
Sale Of Investment
26.67
-49.19%
52.49
+129.18%
22.91
+35.62%
16.89
Net Business Purchase And Sale
6.80
+183.31%
-8.17
-22.50%
-6.67
+76.33%
-28.17
Purchase Of Business
-23.20
-184.02%
-8.17
-22.50%
-6.67
+76.33%
-28.17
Gain Loss On Sale Of Business
-20.91
-315.55%
9.70
0.00
0.00
Net Other Investing Changes
-3.46
-150.69%
6.83
+746.96%
0.81
-41.44%
1.38
Financing Cash Flow
-107.49
-642.11%
-14.48
+43.67%
-25.71
+94.73%
-487.55
Cash Flow From Continuing Financing Activities
-107.49
-642.11%
-14.48
+43.67%
-25.71
+94.73%
-487.55
Net Issuance Payments Of Debt
-20.75
-34.85%
-15.39
+19.51%
-19.12
+95.28%
-405.17
Issuance Of Debt
0.00
-100.00%
235.50
-49.89%
470.00
-68.24%
1,480.00
Repayment Of Debt
-20.75
+91.73%
-250.89
+48.71%
-489.12
+74.05%
-1,885.17
Long Term Debt Issuance
0.00
-100.00%
235.50
-49.89%
470.00
-68.24%
1,480.00
Long Term Debt Payments
-20.75
+91.73%
-250.89
+48.71%
-489.12
+74.05%
-1,885.17
Net Long Term Debt Issuance
-20.75
-34.85%
-15.39
+19.51%
-19.12
+95.28%
-405.17
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
-83.50
-4415.19%
1.94
-51.54%
3.99
+104.80%
-83.11
Common Stock Payments
-86.68
-4990.02%
-1.70
-85.31%
-0.92
+98.96%
-88.51
Repurchase Of Capital Stock
-86.68
-4990.02%
-1.70
-85.31%
-0.92
+98.96%
-88.51
Net Other Financing Charges
-3.25
-214.44%
-1.03
+90.25%
-10.59
-1546.72%
0.73
Changes In Cash
145.30
-7.26%
156.68
+147.00%
63.43
+116.80%
-377.57
Beginning Cash Position
229.94
+213.88%
73.26
+645.70%
9.82
-97.46%
387.39
End Cash Position
375.24
+63.19%
229.94
+213.88%
73.26
+645.70%
9.82
Free Cash Flow
252.63
+36.89%
184.55
+77.46%
104.00
-24.22%
137.23
Interest Paid Supplemental Data
34.38
-14.05%
40.00
-5.38%
42.28
-63.63%
116.23
Income Tax Paid Supplemental Data
—
4.67
-84.85%
30.84
+14.59%
26.91
Common Stock Issuance
3.18
-12.48%
3.64
-25.94%
4.91
-8.97%
5.40
Issuance Of Capital Stock
3.18
-12.48%
3.64
-25.94%
4.91
-8.97%
5.40
Sale Of Business
30.00
0.00
0.00
—
Cash From Discontinued Financing Activities
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category